Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial.
Saved in:
| Title: | Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial. |
|---|---|
| Authors: | Shao, Yueming1 (AUTHOR), Yang, Xinping2 (AUTHOR), Yu, Jianhua3 (AUTHOR), Wang, Xicheng2 (AUTHOR), Wang, Jiangrong1 (AUTHOR), Liu, Mei2 (AUTHOR), Yang, Zongxing3 (AUTHOR), Han, Jie3 (AUTHOR), Zhang, Renfang1 (AUTHOR), Liu, Li1 (AUTHOR), Shen, Yinzhong1 (AUTHOR), Sun, Meiyan1 (AUTHOR), Wu, Luling4 (AUTHOR), Zheng, Zhihang5 (AUTHOR), Tang, Yang1 (AUTHOR), Yang, Junyang1 (AUTHOR), Wang, Zhenyan1 (AUTHOR), Qi, Tangkai1 (AUTHOR), Xu, Shuibao1 (AUTHOR), Xun, Jingna1 (AUTHOR) |
| Source: | Infectious Diseases & Therapy. Jan2026, Vol. 15 Issue 1, p165-181. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
